Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension

医学 左旋西孟旦 米力农 心脏指数 心脏病学 内科学 肺动脉高压 重症监护室 麻醉 心脏外科 心输出量 血流动力学 心力衰竭
作者
Prachi Nag,Saibal Roy Chowdhury,Sukanta Kumar Behera,Mrinalendu Das,Pradeep Narayan
出处
期刊:Journal of Cardiothoracic and Vascular Anesthesia [Elsevier BV]
卷期号:37 (6): 972-979 被引量:10
标识
DOI:10.1053/j.jvca.2023.01.032
摘要

Both milrinone and levosimendan have been used in patients undergoing surgical closure of ventricular septal defects (VSD) with pulmonary artery hypertension (PAH); however, the evidence base for their use is limited. In the present study, the authors sought to compare the role of levosimendan and milrinone in the prevention of low-cardiac-output syndrome in the early postoperative period.A prospective, randomized, controlled trial.At a tertiary-care center.Children between 1 month and 12 years presenting with VSD and PAH between 2018 and 2020.A total of 132 patients were randomized into the following 2 groups: Group L (levosimendan group) and Group M (milrinone group).In addition to conventional hemodynamic parameters, the authors also included a myocardial performance index assessment to compare the groups. The levosimendan group had significantly lower mean arterial pressure while coming off cardiopulmonary bypass, after shifting to intensive therapy unit, as well as at 3 and 6 hours postoperatively. The duration of ventilation (29.6 ± 13.9 hours v 23.2 ± 13.3 hours; p = 0.012), as well as postoperative intensive care unit stay, were significantly prolonged in the levosimendan group (5.48 ± 1.2 v 4.7 ± 1.3 days, p = 0.003). There were 2 (1.6%) in-hospital deaths in the entire cohort, 1 in each arm. There was no difference in the myocardial performance index of the left or right ventricle.In patients undergoing surgical repair for VSD with PAH, levosimendan does not confer any additional benefit compared to milrinone. Both milrinone and levosimendan appear to be safe in this cohort.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
一台小钢炮完成签到,获得积分10
3秒前
wangyf完成签到,获得积分10
5秒前
冷傲海发布了新的文献求助10
6秒前
8秒前
8秒前
11秒前
12秒前
13秒前
偷走太阳去兜风完成签到,获得积分20
14秒前
windy7发布了新的文献求助10
15秒前
大个应助fcyyc采纳,获得10
16秒前
yshu发布了新的文献求助10
16秒前
香蕉觅云应助Lsy采纳,获得50
17秒前
panda完成签到,获得积分10
18秒前
18秒前
19秒前
巧巧发布了新的文献求助10
20秒前
酷波er应助windy7采纳,获得10
21秒前
yangyang发布了新的文献求助10
22秒前
dodo应助yy采纳,获得200
23秒前
谦让文昊完成签到,获得积分10
25秒前
26秒前
眼睛大雨筠应助小合采纳,获得20
28秒前
杰帅完成签到,获得积分10
29秒前
fcyyc发布了新的文献求助10
29秒前
arabidopsis应助害怕的咖啡采纳,获得10
30秒前
30秒前
31秒前
33秒前
34秒前
yshu完成签到,获得积分10
34秒前
36秒前
不安豁发布了新的文献求助10
36秒前
瀼瀼发布了新的文献求助10
36秒前
踏雪完成签到,获得积分10
37秒前
谭成勇发布了新的文献求助10
38秒前
小二郎应助行走的土豆采纳,获得10
39秒前
赘婿应助bao采纳,获得30
40秒前
量子星尘发布了新的文献求助10
40秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3958164
求助须知:如何正确求助?哪些是违规求助? 3504370
关于积分的说明 11118094
捐赠科研通 3235637
什么是DOI,文献DOI怎么找? 1788403
邀请新用户注册赠送积分活动 871211
科研通“疑难数据库(出版商)”最低求助积分说明 802547